e-learning
resources
Stockholm 2002
Monday 16.09.2002
Control of breathing and CNS changes in respiratory failure
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cannabinoid activity in respiratory control
M. Pokorski, A. Casaco Parada (Warsaw, Poland; Havana, Cuba)
Source:
Annual Congress 2002 - Control of breathing and CNS changes in respiratory failure
Session:
Control of breathing and CNS changes in respiratory failure
Session type:
Thematic Poster Session
Number:
1869
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Pokorski, A. Casaco Parada (Warsaw, Poland; Havana, Cuba). Cannabinoid activity in respiratory control. Eur Respir J 2002; 20: Suppl. 38, 1869
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Lane-hamilton syndrome and CCF: a fatal association
Late Breaking Abstract - The mortality predicting factors at admission and during hospitalisation of pateints with SARS COV2
The treatment burden of long-term home noninvasive ventilation
Related content which might interest you:
Prostanoid DP
1
receptor as a target for respiratory diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 214s
Year: 2005
Modulation of cortical and respiratory activity by 5-HT2 receptor agonist in the rat
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008
Synthetic cannabinoids induce acute lung inflammation
via
cannabinoid receptor 1 activation
Source: ERJ Open Res, 6 (3) 00121-2020; 10.1183/23120541.00121-2020
Year: 2020
EP2 & EP4 receptor agonists inhibit the airway sensory nerves that cause cough, a potential protective control that is lost in human smokers and a pre-clinical COPD model
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017
Attenuation of ozone-induced tachypnoea by activation of dopamine D
2
receptors in the rat: involvement of vagal bronchopulmonary C fibres
Source: Eur Respir J 2001; 18: Suppl. 33, 408s
Year: 2001
Changes in respiratory drive and respiratory sensations with respiratory muscle fatigue
Source: Eur Respir J 2004; 24: Suppl. 48, 577s
Year: 2004
Neural respiratory drive in respiratory disease patients
Source: International Congress 2018 – Respiratory muscles at rest, during exercise and in the critically ill patient
Year: 2018
Cholinergic muscarinic receptors and airway remodelling in severe asthma
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018
Neurokinin-1 receptor antagonism for the treatment of cough in lung cancer
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016
Condition function of the respiratory system is one of the nonrespiratory lung functions
Source: Eur Respir J 2002; 20: Suppl. 38, 58s
Year: 2002
Nicotinic alpha-7 receptor stimulation (a7nAChR) inhibited NF-kB/STAT3/SOCS3 pathways in a murine model of asthma.
Source: International Congress 2017 – Novel mechanisms and treatments for asthma
Year: 2017
Different alcohols activate airway sensory nerves by a vanilloid receptor 1 (TRPV1) dependent mechanism
Source: Eur Respir J 2003; 22: Suppl. 45, 415s
Year: 2003
Evidence of biological efficacy for prolonged glucocorticoid treatment in patients with unresolving ARDS
Source: Eur Respir J 2003; 22: 57S-64S
Year: 2003
Inhibition of cough reflex by D
2
receptor agonism with Viozan™ (AR-C68397AA)
Source: Eur Respir J 2001; 18: Suppl. 33, 32s
Year: 2001
Variable tissue expression of transferrin receptors: relevance to acute respiratory distress syndrome
Source: Eur Respir J 2003; 22: 335-341
Year: 2003
Damage and expression of TNF receptors in respiratory muscles of COPD patients: temporal sequence
Source: Annual Congress 2008 - Respiratory muscle pathophysiology
Year: 2008
AI for respiratory signals
Source: Virtual Congress 2020 – Insights from wearable respiratory sensors and AI
Year: 2020
Modulation of transient receptor potential vanilloid-1 (TRPV1) by inhaled prostaglandin-E2 (PGE2) and bradykinin (BK) is associated with increased cough sensitivity to capsaicin (CPS) and autonomic dysregulation of cardiac rhythm in healthy subjects
Source: Virtual Congress 2020 – Occupational and environmental causes of respiratory disease
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept